TB impact in numbers - John McKinney (EPFL)

TL;DR

TB and HIV/AIDS synergistically worsen global health crises.

Transcript

according to the world health organization of the 57 million or so people who die every year of various causes so this is of all causes combined worldwide about one in four individuals die of one or another infectious disease among infectious diseases the big three are tuberculosis hiv aids and malaria which together account for something like six ... Read More

Key Insights

• Tuberculosis, HIV/AIDS, and malaria are the three leading infectious diseases, causing six to seven million deaths annually worldwide.
• Tuberculosis is the primary cause of death among HIV/AIDS-infected individuals, highlighting a dangerous synergy between the two diseases.
• The visible impact of tuberculosis, with two million deaths annually, is just the tip of the iceberg compared to the latent cases.
• Approximately 16 to 20 million people have active tuberculosis at any given time, contributing to the disease's transmission.
• One in three people globally harbors the tubercle bacillus in a latent form, posing a significant risk for future active disease development.
• Individuals with latent tuberculosis have a 10% lifetime risk of developing active tuberculosis, which escalates with HIV co-infection.
• Even with a hypothetical transmission-blocking vaccine, 200 million new TB cases could arise over the next 50 years due to latent reactivation.
• Current interventions for latent TB, like nine months of chemoprophylaxis with isoniazid, are impractical on a global scale.

Questions & Answers

Q: What are the leading infectious diseases causing global deaths?

The leading infectious diseases contributing to global deaths are tuberculosis, HIV/AIDS, and malaria. Together, these diseases account for six to seven million deaths each year. Tuberculosis, in particular, is the leading cause of death among individuals infected with HIV/AIDS, indicating a significant public health challenge.

Q: How do tuberculosis and HIV/AIDS interact to worsen health outcomes?

Tuberculosis and HIV/AIDS interact in a way that exacerbates health outcomes. Being immunocompromised due to HIV/AIDS increases susceptibility to tuberculosis. Conversely, active tuberculosis accelerates the progression from HIV infection to AIDS. This synergy creates a compounded health crisis, particularly in developing countries, where both diseases are prevalent.

Q: What is the significance of latent tuberculosis in global health?

Latent tuberculosis poses a significant global health risk because it involves a large number of individuals who harbor the tubercle bacillus without active disease. This latent infection represents a reservoir for potential reactivation, leading to new active TB cases. With about one-third of the global population affected, it underscores the need for effective interventions.

Q: What challenges exist in treating latent tuberculosis?

Treating latent tuberculosis presents challenges due to the impracticality of current interventions, such as nine months of chemoprophylaxis with isoniazid. This treatment is not feasible on a large scale, given the vast number of individuals affected. The lack of effective and practical tools to address latent TB remains a significant unmet need in global health.

Q: How could future TB cases arise despite current interventions?

Future TB cases could arise due to the reactivation of existing latent infections. Even with a hypothetical vaccine to block transmission, latent TB cases could lead to 200 million new infections over the next 50 years. This highlights the importance of addressing latent TB to prevent a future surge in active cases.

Q: What is the iceberg analogy in the context of tuberculosis?

The iceberg analogy illustrates that the visible impact of tuberculosis, such as the two million annual deaths, is only a small part of the problem. The larger issue lies beneath the surface, with millions of active and latent TB cases that contribute to ongoing transmission and future disease burden, posing a significant threat to global health.

Q: What is the lifetime risk of developing active TB from a latent infection?

The lifetime risk of developing active tuberculosis from a latent infection is approximately 10%. This risk significantly increases for individuals co-infected with HIV/AIDS, rising to about 10% per year. This elevated risk underscores the critical need for effective strategies to manage latent TB, especially in populations with high HIV prevalence.

Q: Why is there an urgent need for new TB interventions?

There is an urgent need for new TB interventions because current strategies are insufficient to address the widespread issue of latent TB. The impracticality of existing treatments, coupled with the potential for millions of new cases due to latent reactivation, necessitates the development of new, effective, and scalable solutions to combat tuberculosis globally.

Summary & Key Takeaways

• Tuberculosis, alongside HIV/AIDS and malaria, ranks among the top infectious diseases, causing millions of deaths annually. The synergy between TB and HIV/AIDS exacerbates health crises, as TB accelerates HIV progression. Despite the high death toll, the greater threat lies in the millions of latent TB cases globally.

• The iceberg analogy illustrates TB's hidden impact: while two million deaths are visible, 16 to 20 million active cases and two billion latent infections remain unseen. These latent cases, if reactivated, could perpetuate TB's spread, highlighting the urgent need for effective interventions.

• Current treatments for latent TB, such as prolonged isoniazid therapy, are impractical for widespread use. Without new solutions, latent TB will continue to pose a significant threat to global health, potentially leading to millions of new cases in the coming decades.